Scar Management
Some patients may develop Hypertrophic (scar that are raised, wide and red), or Keloid (Scar that have a raised shape that extends beyond the borders of the initial scar)
Scars take approximately one year to reach their final, “mature” form. As such, usually it is advisable to wait at least one year until scar revision or treatment options are undertaken.
Avoid sun exposure to the scar area during the first year of healing.
Hypertrophic scar tend to develop due to tension at the area of scar. Over time, if the area of skin becomes more relaxed, the scar may be amenable to revision by surgically removing it and “re-doing” the scar. There is still a chance of recurrence, but often scar revision is quite effective in hypertrophic scars. Steroid injection into the scar may also improve the scar quality.
Keloid scars are more difficult to treat and have a high chance of recurrence. Some treatment options include steroid injection into the scar, excision with injection of steroid at the time of excision, compression therapy, and radiation therapy.
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is not breast cancer - it is a type of non-Hodgkin's lymphoma (cancer of the immune system). In 2016, the World Health Organization labelled BIA-ALCL as a T-cell lymphoma that can develop following breast implants.
In most cases, BIA-ALCL is found in the scar tissue and fluid near the implant, but in some cases, it can spread throughout the body. The risk of person with breast implants developing BIA-ALCL is considered low. However, this cancer is serious and needs to be treated promptly. BIA-ALCL is treated with surgery to remove the implant and surrounding scar tissue. Chemotherapy and radiation therapy are also recommended in some patients.
The main symptoms of BIA-ALCL are persistent swelling, presence of a mass or pain in the area of the breast implant. These symptoms may occur well after the surgical incision has healed, often years after implant placement.
The risk of BIA-ALCL is higher for textured surface implants versus smooth surface implants. In Canada, textured implants are no longer used. For patients who have a textured surface implant right now but have no symptoms, removal is not recommended.
If you have textured surface implants, or questions about BIA-ALCL, talk to your surgeon. Helpful information can also be found through the Canadian Society of Plastic Surgeons.
https://plasticsurgery.ca/medical-professionals/information-plastic-surgeons/alcl/
Drain Care
Drains are a simple device that may be placed at the end of surgery to help remove fluid and blood from any areas that may be prone to collect them.
You may have to go home with drains if the output remains too high to be removed.
The drain output will usually be blood mixed with body fluids (clear/straw colour fluid), and will become less bloody as days pass from your surgery, and more straw coloured. You may notice small stringy bits of blood, which are normal bits of clot and tissue.
If you start to notice a large increase in bright red bleeding in your drains, or cloudy or foul smelling drain outputs, let your surgeon know or proceed to the emergency department if you are feeling unwell or have sudden changes to your breast.
The nursing team will show you how to care for your drains before you leave hospital. General steps include:
Wash your hands
Release suction valve of drain bulb
Record amount of fluid collected
Discard fluid in toilet
Squish bulb to re-establish suction, then plug the suction valve hole.
Secure the drain bulbs on your clothes so that they don’t catch on things when you are moving around the house.